Liver cells are indispensable for research—for drug testing, to better understand diseases such as hepatitis, fatty liver, ...

Explore how smart automation enables precise, reproducible workflows in anaerobic microbiome research, improving accuracy and ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

CollaBraid is the first product the company aims to bring to market in 2026. The technology is a hybrid collagen suture — a thread-like material that surgeons use to stitch tissue together — for a ...

CREATE Medicines, Inc. (formerly Myeloid Therapeutics) today announced new preclinical data for RetroT, the company's fully RNA-encoded, site-specific gene-integration system, presented at the Cold ...

Treatments for asthma, chronic rhinosinusitis with nasal polyps, dyslipidemia, Cushing syndrome, gonorrhea, HSCT-associated thrombotic microangiopathy, marginal zone lymphoma, motion sickness, ...

Pancreas development in pigs resembles humans much more closely than does the established mouse model. An international team ...

Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development- ...

Peter A. Calabresi, M.D., professor and chair of the Department of Neurological Sciences at the University of Vermont’s Robert Larner, M.D. College of Medicine and University of Vermont Health (UVMH), ...

As per the tender conditions, each analyzer will be supplied with standard accessories and a three-year warranty, followed by ...

This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical ...

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is gen ...